tirzepatide maker Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Drug makers can't make knockoff

One such medication is Semaglutide GLP-1, which is primarily used to manage type 2 diabetes but has shown encouraging results in weight management

Biosci Rep (2019) 39(12):BSR20192009

Individual metabolism Semaglutide response also varies among individuals according to their metabolic health

Analysis by MavenBio highlights that while other pharma companies have broad, diversified portfolios Lilly is the most concentrated large pharma companies: cardiometabolic therapies generated $13.8B, representing over 78% of total pharma revenue

KYBELLA Kybella is the only FDA-approved injectable treatment that destroys fat cells in the treatment area under the chin to improve your profile